Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |